1.Effect of Ruigan on liver function of Perioperative Treatment in Obstructive Jaundice
Chinese Journal of Primary Medicine and Pharmacy 2009;16(7):1248-1249
Objective To investigate the effect of Ruigan (L-omithine-L-aspartate) on liver function of perio-perative treatment. Methods 58 patients with obstructive jaundice and having been done operation were randomly di-vided into two groups:ruigan group (cured group,32 cases) and routine hugan group (control group,26 cases). The levels of liver function and endotoxin were detected when being in hospital, before operation and after operation re-spectively. Results Treatment with ruigan could improve the liver function in perioperation, which has significant difference when compared to the control group (P < 0.05).. Ruigan could reduce the level of endotoxin before and af-ter operation (P < 0.05) and improve endotoxaemia in obstructive jaundice. Conclusion Ruigan would improve the liver function and the endotoxaemia in the perioperative obstructive jaundice.
2.Treatment for early acute pancreatitis of closed abdominal injury by ultrasound-guided percutaneous tube drainage
Bozhi CHEN ; Kanglin ZHONG ; Lili LIU
Chinese Journal of Primary Medicine and Pharmacy 2008;15(4):611-612
Objective To investigate the effect of ultrasound-guided percutaneous tube drainage in early acute pancreatitis of closed abdominal injury. Methods The clinical data about fifteen ca.ses of acute pancreatitis of closed abdominal injury in our hospital were reviewed retrospectively. Results By ultrasound-guided percutaneous tube drainage, 11 cases were cured, 2 cases were drainaged by open operation with the complication of pancreatic pseudocyst, 2 eases were transfered to superior hospital with state of an illness sharpened. Conclusion Ultrasoundguided percutaneous tube drainage was effective treatment in early acute pancreatitis of dosed abdominal injury,and avoided open operation.
3.Relationship between serum sRAGE, 25-hydroxyvitamin-D3, NLRP3 and cognitive impairment in patients with hypertensive cerebral hemorrhage
Jinbo WU ; Chunlan YANG ; Zhenxing YAO ; Kaiwen ZHENG ; Bozhi ZHONG ; Wenjia LIN
Journal of Chinese Physician 2021;23(10):1492-1495,1500
Objective:To investigate the relationship between serum 25 hydroxyvitamin-D3, soluble advanced glycation end product receptor (sRAGE), nucleotide binding oligomerization domain like receptor 3 (NLRP3) mRNA and cognitive impairment in hypertensive intracerebral hemorrhage (HICH).Methods:143 patients with HICH treated in the Affiliated Hospital of Guangdong Medical University from July 2016 to July 2019 were selected as the research objects. Among the 143 patients with HICH, there were 68 patients with cognitive impairment (cognitive impairment group) and 75 patients without cognitive impairment (control group). The age, gender, amount of intracerebral hemorrhage, bleeding site, blood pressure, blood glucose and blood lipid of the two groups were counted, and the mRNA levels of 25 hydroxyvitamin-D3, sRAGE and NLRP3 were detected. Multivariate logistic regression analysis was used to analyze the risk factors of cognitive impairment in patients with HICH.Results:There were no significant differences in age, gender, smoking, education, bleeding site, diabetes rate, triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C) between cognitive dysfunction group and control group ( P>0.05); There were significant differences in bleeding volume and neurological function defect score (NIHSS) score between cognitive impairment group and control group ( P<0.05); The level of 25 hydroxyvitamin-D3 in cognitive impairment group was lower than that in control group ( P<0.05), and the expression level of NLRP3 mRNA was higher than that in control group ( P<0.05). There was no significant difference in sRAGE between the two groups ( P>0.05); Logistic regression analysis showed that the decrease of 25-hydroxyvitamin-D3 level, the increase of bleeding volume and NIHSS score were independent risk factors for cognitive impairment in HICH patients ( P<0.05). Conclusions:Decreased serum 25 hydroxyvitamin-D3 levels may increase the risk of cognitive impairment in patients with HICH.